Full-length cellular β-secretase has a trimeric subunit stoichiometry, and its sulfur-rich transmembrane interaction site modulates cytosolic copper compartmentalization

The β-secretase (BACE1) initiates processing of the amyloid precursor protein (APP) into Aβ peptides, which have been implicated as central players in the pathology of Alzheimer disease. BACE1 has been described as a copper-binding protein and its oligomeric state as being monomeric, dimeric, and/or...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 292; no. 32; pp. 13258 - 13270
Main Authors Liebsch, Filip, Aurousseau, Mark R.P., Bethge, Tobias, McGuire, Hugo, Scolari, Silvia, Herrmann, Andreas, Blunck, Rikard, Bowie, Derek, Multhaup, Gerd
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 11.08.2017
American Society for Biochemistry and Molecular Biology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The β-secretase (BACE1) initiates processing of the amyloid precursor protein (APP) into Aβ peptides, which have been implicated as central players in the pathology of Alzheimer disease. BACE1 has been described as a copper-binding protein and its oligomeric state as being monomeric, dimeric, and/or multimeric, but the native cellular stoichiometry has remained elusive. Here, by using single-molecule fluorescence and in vitro cross-linking experiments with photo-activatable unnatural amino acids, we show that full-length BACE1, independently of its subcellular localization, exists as trimers in human cells. We found that trimerization requires the BACE1 transmembrane sequences (TMSs) and cytoplasmic domains, with residues Ala463 and Cys466 buried within the trimer interface of the sulfur-rich core of the TMSs. Our 3D model predicts that the sulfur-rich core of the trimeric BACE1 TMS is accessible to metal ions, but copper ions did not trigger trimerization. The results of functional assays of endogenous BACE1 suggest that it has a role in intracellular copper compartmentalization by transferring cytosolic copper to intracellular compartments, while leaving the overall cellular copper concentration unaltered. Adding to existing physiological models, our results provide novel insight into the atypical interactions between copper and BACE1 and into its non-enzymatic activities. In conclusion, therapeutic Alzheimer disease prevention strategies aimed at decreasing BACE1 protein levels should be regarded with caution, because adverse effects in copper homeostasis may occur.
Bibliography:Supported by a Fonds de recherche du Québec – Nature et technologies (FRQNT) doctoral research grant.
Supported by NSERC Grant DG 327201-2012 and CIHR Grant MOP 136894.
Supported by a Banting and Best graduate fellowship from the CIHR.
Present address: Institute for Laboratory Medicine, Kantonsspital Aarau, CH-5001 Aarau, Switzerland.
Edited by Paul E. Fraser
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M117.779165